Undiscovered Gems In Hong Kong To Watch This September 2024

In This Article:

As global markets grapple with economic uncertainties, the Hong Kong market has shown resilience, particularly in its small-cap sector. With key indices reflecting mixed sentiments and economic indicators suggesting cautious optimism, now might be an opportune time to identify promising stocks that could offer growth potential despite broader market challenges. In this context, a good stock typically exhibits strong fundamentals, innovative business models, and the ability to navigate economic headwinds effectively. Here are three undiscovered gems in Hong Kong that merit close attention this September 2024.

Top 10 Undiscovered Gems With Strong Fundamentals In Hong Kong

Name

Debt To Equity

Revenue Growth

Earnings Growth

Health Rating

Lion Rock Group

16.91%

14.33%

10.15%

★★★★★★

E-Commodities Holdings

21.33%

9.04%

28.46%

★★★★★★

PW Medtech Group

0.06%

22.33%

-17.56%

★★★★★★

COSCO SHIPPING International (Hong Kong)

NA

-3.84%

16.33%

★★★★★★

Tianyun International Holdings

10.09%

-5.59%

-9.92%

★★★★★★

S.A.S. Dragon Holdings

60.96%

4.62%

10.02%

★★★★★☆

HBM Holdings

52.89%

66.59%

31.70%

★★★★★☆

TIL Enviro

47.97%

-23.09%

-8.84%

★★★★☆☆

Pizu Group Holdings

48.34%

-4.53%

-19.78%

★★★★☆☆

Billion Industrial Holdings

3.63%

18.00%

-11.38%

★★★★☆☆

Click here to see the full list of 172 stocks from our SEHK Undiscovered Gems With Strong Fundamentals screener.

We're going to check out a few of the best picks from our screener tool.

IVD Medical Holding

Simply Wall St Value Rating: ★★★★★☆

Overview: IVD Medical Holding Limited, with a market cap of HK$1.99 billion, is an investment holding company that distributes in vitro diagnostic (IVD) products in Mainland China and internationally.

Operations: IVD Medical Holding generates revenue primarily from its Distribution Business (CN¥2.86 billion), followed by After-sales services (CN¥196.47 million) and Self-Branded Products Business (CN¥9.05 million).

IVD Medical Holding reported half-year sales of CNY 1.35 billion, slightly down from CNY 1.38 billion last year, but net income rose to CNY 125.29 million from CNY 103.01 million. Earnings per share increased to CNY 0.0927 from CNY 0.0762 a year ago, despite the company’s debt-to-equity ratio climbing from 5.4% to 23% over five years and recent shareholder dilution due to a HKD189 million equity offering in June.

SEHK:1931 Earnings and Revenue Growth as at Sep 2024
SEHK:1931 Earnings and Revenue Growth as at Sep 2024

YesAsia Holdings

Simply Wall St Value Rating: ★★★★★★

Overview: YesAsia Holdings Limited, with a market cap of HK$2.63 billion, is an investment holding company that focuses on the procurement, sale, and trading of Asian fashion and lifestyle, beauty, cosmetics, accessories, and entertainment products.